https://doi.org/10.4081/ijwc.2020.56
Grey-zone in the treatment of patients with Diabetic Foot. The results of an Italian multidiscipli-nary Delphi survey conducted among a group of experts
Accepted: July 24, 2020
PDF: 60
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Diabetic foot is one of the most severe complications of Diabetes Mellitus (DM) and the leading cause of non-traumatic amputation of the lower limbs, with an estimated one million people with DM undergoing radical treatment each year as a result of this condition. Despite the existence of national and international guidelines on diabetic foot management, in some aspects of managementthe recommendations given are not supported by a strong body of evidence. This can be a potential source of uncertainty in decision-making, but also a starting point for clarification of aspects related to diabetic foot management in Italian practice. The objective of this document is, therefore, to recalibrate the international recommendations on diabetic foot management in the light of the opinions of Italian experts.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.